CLINICAL EFFICACY OF DIRITHROMYCIN VERSUS MIOCAMYCIN IN THE TREATMENT OF ACUTE BRONCHITIS OR ACUTE EXACERBATIONS OF CHRONIC-BRONCHITIS

被引:7
作者
POZZI, E
机构
[1] Respiratory Disease Division, Department of Clinical and Biological Sciences, University of Twin, Turin
关键词
D O I
10.1093/jac/31.suppl_C.153
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
A multicentre trial was carried out to compare the efficacy and safety of dirithromycin with miocamycin in the treatment of patients with acute bronchitis or acute exacerbations of chronic bronchitis. The study was a single blind, randomized, parallel group study. Dirithromycin was administered orally at a dosage of 500 mg once daily and miocamycin was administered orally at a dosage of 600 mg twice daily; the duration of therapy was five to seven days for both drugs. The results, in 161 assessable patients (78 taking dirithromycin; 83 taking miocamycin), show that dirithromycin and miocamycin have comparable efficacy and safety in the treatment of bronchitis caused by susceptible bacterial pathogens. © 1993 The British Society for Antimicrobial Chemotherapy.
引用
收藏
页码:153 / 158
页数:6
相关论文
共 9 条
[1]  
[Anonymous], 1965, Lancet, V1, P775
[2]   PENETRATION OF ANTIBIOTICS INTO THE RESPIRATORY TREE [J].
BERGOGNEBEREZIN, E .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1981, 8 (03) :171-174
[3]  
BUSCH U, 1988, 8TH INT S FUT TRENDS
[4]   NEW DIRECTIONS FOR MACROLIDE ANTIBIOTICS - PHARMACOKINETICS AND CLINICAL EFFICACY [J].
KIRST, HA ;
SIDES, GD .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (09) :1419-1422
[5]  
MEDICI TC, 1971, AM REV RESPIR DIS, V103, P784
[6]  
Nicotra M B, 1988, Semin Respir Infect, V3, P61
[7]  
PUCHELLE E, 1980, EUR J RESPIR DIS, V61, P254
[8]  
SOUTAR A, 1977, THORAX, V32, P387
[9]  
1962, AM REV RESPIR DIS, V86, P762